SCHEMBL1386473

SCHEMBL1386473

CC(C)C(N)N1CCNCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25088955 0.81 TOP2A (0.30)
SCHEMBL761343 0.80 MAPT (0.33)
Bromide SCHEMBL28429281 0.79
SCHEMBL8141548 0.77 CHRM5 (0.30)
SCHEMBL5452977 0.76 MEN1 (0.37)
SCHEMBL25959958 0.76
Hydrochloric Acid SCHEMBL3499071 0.75 MEN1 (0.36)
SCHEMBL28429854 0.74 MDM4 (0.31)
SCHEMBL8486661 0.74
SCHEMBL28429227 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4829449-B2 2011-12-07 JP claimed
JP-2003508353-A 2003-03-04 JP claimed
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP claimed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO claimed